These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 111287)

  • 21. Variability in development of tolerance to repeated injections of low doses of dl-amphetamine in rats.
    Thornhill JA; Hirst M; Gowdey CW
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1170-8. PubMed ID: 562704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levoamphetamine and dextroamphetamine: differential effect on aggression and hyperkinesis in children and dogs.
    Arnold LE; Kirilcuk V; Corson SA; Corson EO
    Am J Psychiatry; 1973 Feb; 130(2):165-70. PubMed ID: 4568123
    [No Abstract]   [Full Text] [Related]  

  • 23. A cntral site for the hypothermic effects of (+)-amphetamine sulphate and p-hydroxyamphetamine hydrobromide in mice.
    McCullough DO; Milberg JN; Robinson SM
    Br J Pharmacol; 1970 Oct; 40(2):219-26. PubMed ID: 5492894
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of phencyclidine on amphetamine stereotypy in rats.
    Balster RL; Chait LD
    Eur J Pharmacol; 1978 Apr; 48(4):445-50. PubMed ID: 565717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blood pressure and heart rate responses evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine. I. The relationship between evoked responses and plasma levels of drug.
    Simpson LL
    J Pharmacol Exp Ther; 1979 Oct; 211(1):225-30. PubMed ID: 40013
    [No Abstract]   [Full Text] [Related]  

  • 26. Relative potency of amphetamine isomers in causing the serotonin behavioral syndrome in rats.
    Sloviter RS; Damiano BP; Connor JD
    Biol Psychiatry; 1980 Oct; 15(5):789-96. PubMed ID: 7417631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of amphetamines in hyperkinetic children: stimulant of sedative? A pilot study.
    Montagu JD; Swarbrick L
    Dev Med Child Neurol; 1975 Jun; 17(3):293-8. PubMed ID: 1204982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence that a behavioral augmentation following repeated amphetamine administration does not involve peripheral mechanisms.
    Kuczenski R; Segal DS; Weinberger SB; Browne RG
    Pharmacol Biochem Behav; 1982 Sep; 17(3):547-53. PubMed ID: 6890688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effects of different amphetamines on copulatory behaviour and stereotype activity in the female rat, after treatment with monoamine depletors and synthesis inhibitors.
    Michanek A; Meyerson BJ
    Arch Int Pharmacodyn Ther; 1977 Oct; 229(2):301-12. PubMed ID: 145834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lithium and amphetamine hyperactivity in rats. Differential effect on d and l isomers?
    Flemenbaum A
    Neuropsychobiology; 1975; 1(6):325-34. PubMed ID: 1241950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A canine model used to simultaneously assess potential neurobehavioural and cardiovascular effects of candidate drugs.
    Tontodonati M; Fasdelli N; Moscardo E; Giarola A; Dorigatti R
    J Pharmacol Toxicol Methods; 2007; 56(2):265-75. PubMed ID: 17587603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems.
    Matsuda LA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):901-8. PubMed ID: 2600821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioural effects of amphetamine in a small primate: relative potencies of the d- and l-isomers.
    Scraggs PR; Ridley RM
    Psychopharmacology (Berl); 1978 Dec; 59(3):243-5. PubMed ID: 104327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation of the effects of scopolamine and d-amphetamine on a spontaneous alternation task.
    Kokkinidis L; Anisman H
    Pharmacol Biochem Behav; 1976 Sep; 5(3):293-7. PubMed ID: 996062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine.
    Arai Y; Kim SK; Kinemuchi H; Tadano T; Satoh SE; Satoh N; Kisara K
    J Neurochem; 1990 Aug; 55(2):403-8. PubMed ID: 2370545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anorexic and behavioural effects of a new imidazo-isoindole derivative (mazindol) in comparison with d-amphetamine in the rat.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacology; 1977; 15(1):46-56. PubMed ID: 557207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modulation of the behavioral effects of amphetamine in rats by clonidine.
    Mueller K; Nyhan WL
    Eur J Pharmacol; 1982 Sep; 83(3-4):339-42. PubMed ID: 6293845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. d-Amphetamine in squirrel monkeys of different social status: effects on social and agonistic behavior, locomotion, and stereotypies.
    Miczek KA; Gold LH
    Psychopharmacology (Berl); 1983; 81(3):183-90. PubMed ID: 6417706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of pyrazolone-5 derivatives on amphetamine-induced hyperthermia and behavioural changes in rats.
    Misterek K; Klimecka H
    Pol J Pharmacol Pharm; 1976; 28(6):593-9. PubMed ID: 1034922
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.